Product Information
BUPRENORPHINE 2 MG TABLET SL is a generic product labeled by American Health Packaging, priced at $0.2648 per EA under NDC 60687048121. Its NADAC has been published 337 times since Mar 11, 2020.
FDA first approved this application on Mar 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
American Health PackagingNDC
60687048121
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207276FDA Approved
3/27/2017
TE Code
AB
On Market Since
2/6/2020
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 2 MG TABLET SL has been published 337 times since Mar 11, 2020, and over the history we have for it it has declined 52.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2648 per EA |
|---|---|
| All-time high | $0.6289 (Sep 11, 2024) |
| All-time low | $0.2629 (Jun 17, 2026) |
| 52-week high | $0.3179 |
| 52-week low | $0.2629 |
| Median price | $0.4234 |
| Average price | $0.4238 |
| Largest weekly change | +42.0% (Aug 21, 2024) |
| Weeks tracked | 337 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 2 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 2 MG TABLET SL, manufactured by American Health Packaging, is $0.2648 per EA (NDC 60687048121), effective Aug 19, 2026.
How has the price of BUPRENORPHINE 2 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 2 MG TABLET SL has declined 52.5%. It has been tracked across 337 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 2 MG TABLET SL?
Since Mar 11, 2020, the NADAC for BUPRENORPHINE 2 MG TABLET SL has ranged from a low of $0.2629 (Jun 17, 2026) to a high of $0.6289 (Sep 11, 2024), with a median of $0.4234 per EA.
Are there cheaper alternatives to BUPRENORPHINE 2 MG TABLET SL?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 2 MG TABLET SL in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE 2 MG TABLET SL?
BUPRENORPHINE 2 MG TABLET SL (NDC 60687048121) is labeled by American Health Packaging, and CMS classifies it as a generic product.